Mach 1 Financial Group LLC Takes Position in Tenet Healthcare Corporation $THC

Mach 1 Financial Group LLC bought a new position in Tenet Healthcare Corporation (NYSE:THC) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 3,244 shares of the company’s stock, valued at approximately $645,000.

Other hedge funds have also modified their holdings of the company. NewEdge Advisors LLC lifted its stake in shares of Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after buying an additional 166 shares in the last quarter. Jones Financial Companies Lllp increased its stake in Tenet Healthcare by 299.1% in the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after buying an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC bought a new stake in Tenet Healthcare during the second quarter valued at about $290,000. Quantbot Technologies LP purchased a new position in shares of Tenet Healthcare in the second quarter valued at about $65,000. Finally, Amundi grew its position in shares of Tenet Healthcare by 4,207.8% during the second quarter. Amundi now owns 27,010 shares of the company’s stock worth $4,652,000 after purchasing an additional 26,383 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors.

Tenet Healthcare Stock Down 5.0%

Shares of NYSE:THC opened at $177.96 on Friday. The company has a 50-day moving average price of $195.29 and a 200 day moving average price of $203.09. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a 12 month low of $146.60 and a 12 month high of $247.21. The company has a market cap of $15.33 billion, a price-to-earnings ratio of 9.25, a PEG ratio of 1.24 and a beta of 1.30.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. The business had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The company’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the prior year, the business posted $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities research analysts predict that Tenet Healthcare Corporation will post 17.64 earnings per share for the current year.

Insider Buying and Selling

In other Tenet Healthcare news, insider R. Scott Ramsey sold 8,017 shares of Tenet Healthcare stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total transaction of $1,865,555.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Paola M. Arbour sold 6,500 shares of the business’s stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the transaction, the executive vice president owned 29,291 shares in the company, valued at $6,983,853.13. This trade represents a 18.16% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 46,517 shares of company stock worth $10,943,111 over the last three months. 0.97% of the stock is owned by insiders.

Wall Street Analyst Weigh In

THC has been the topic of a number of research analyst reports. Leerink Partners boosted their price target on Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a report on Friday, February 20th. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a research report on Thursday, February 12th. Truist Financial upped their target price on shares of Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Royal Bank Of Canada cut their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research note on Friday, May 1st. Finally, Morgan Stanley set a $254.00 price target on shares of Tenet Healthcare in a research note on Friday, May 1st. Nineteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $244.16.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.